Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
12/2003
12/11/2003US20030229070 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action
12/11/2003US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229026 Agents and methods for the treatment of proliferative diseases
12/11/2003US20030226996 Organic semiconductor material and organic electronic device
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1058687B1 Nucleosides
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099217A2 Methods of treating bacterial infections and diseases associated therewith
12/04/2003WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
12/04/2003WO2003010138A3 Piperidine derivatives as antibacterial agents
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003US20030225273 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225148 Biological methods of use of 4-amino-3-mercapto-triazoles
12/04/2003US20030225093 Cyclic gmp-specific phosphodiesterase inhibitors
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030225007 Sulfonamide derivatives of 3-substituted imidazol[1,2-d]-1,2,4-thiadiazoles and 3-substituted-[1,2,4] thiadiazolo[4,5-a] benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
12/04/2003US20030224391 Rigidized trimethine cyanine dyes
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2490062A1 Methods of treating bacterial infections and diseases associated therewith
12/04/2003CA2486821A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/02/2003US6657064 For use as analgesics
12/02/2003US6656940 Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
11/2003
11/27/2003WO2003065983A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/27/2003US20030220365 Administering a biheterocyclic compound for treating reperfusion injuries and inflammatory diseases
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1017700B1 Macrocyclic porphyrazine-type compounds, metal derivatives thereof and process for their preparation
11/26/2003EP1000028B1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/26/2003EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/25/2003US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653086 Fusion protein; ligand has not been identified; screening for agonists/ antagonists
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216374 Antibiotic oxazolidinone derivatives
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP0719779B1 Substituted thiazolo [3,2-alpha]azepine derivative
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649387 Enzymatic oxidative deamination process
11/18/2003US6649335 Cyanine dye
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003057672A3 Tetrahydroquinoline analogues as muscarinic agonists
11/13/2003WO2003053344A3 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003US20030212116 Contorlling plant disease
11/13/2003US20030212111 Controlling concentration of cholesterol, triglyceride, bile acid
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1140097B1 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/11/2003US6645981 Antimicrobial quinolones, their compositions and uses
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002076375A3 Process for the preparation of benazepril
11/06/2003US20030208082 Nitrogen compounds such as 4,5-diisopropyl-1-methyl-2-styryl -1H-imidazole, used as glutamate receptor antagonists, for prophylaxis of psychological disorders, as anxiolytic agents and analgesics
11/06/2003US20030208066 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
11/06/2003US20030207885 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207868 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/06/2003US20030207842 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for
11/06/2003US20030207305 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003CN1453281A Pyridyl carbimide derivative of pyrimidyl thiobiazole with herbicidal activity and its prepn
11/04/2003US6642264 Thiazolobenzoimidazole derivatives
11/04/2003US6642263 Modulators of Rho C activity
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
10/2003
10/31/2003WO2002085909A1 9-deazaguanine derivatives as inhibitors of gsk-3
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089441A1 Tricyclic mercaptans, method for their production and the use thereof as mmp inhibitors
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 152